Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial.

Bode, U; Zimmermann, M; Moser, O; Rutkowski, S; Warmuth-Metz, M; Pietsch, T; Kortmann, R D; Faldum, A; Fleischhack, G

Bode, U; Zimmermann, M; Moser, O; Rutkowski, S; Warmuth-Metz, M; Pietsch, T; Kortmann, R D; Faldum, A; Fleischhack, G.

Affiliation

Bode U; Department of Pediatrics, Hematology/Oncology, Children`s Hospital, University of Bonn, Adenauerallee 119, 53113, Bonn, Germany, Udo.bode@ukb.uni-bonn.de.

J Neurooncol ; 120(3): 635-42, 2014 Dec.

Article in En | MEDLINE | ID: mdl-25179451

Subject(s)

Brain Neoplasms/therapy; Neoplasm Recurrence, Local/therapy; Neuroectodermal Tumors, Primitive/therapy; Stem Cell Transplantation/methods; Adolescent; Adult; Brain Neoplasms/pathology; Child; Child, Preschool; Combined Modality Therapy/adverse effects; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local/pathology; Neuroectodermal Tumors, Primitive/pathology; Prognosis; Stem Cell Transplantation/adverse effects; Survival Analysis; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Neuroectodermal Tumors, Primitive / Stem Cell Transplantation / Neoplasm Recurrence, Local Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: J Neurooncol Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google